July 2009
- Anupam Agarwal, M.D.
- Site-Specific Overexpression of Heme Oxygenase-1 in Acute Kidney Injury
- American Heart Association
- New
- $21,770 7/1/09 - 6/30/10
- Anupam Agarwal, M.D.
- Human Heme Oxygenase-1 Gene Regulation in Renal Injury
- NIH
- Non-Competing Continuation
- $308,125 7/1/09 - 6/30/10
- Michal Mrug, M.D.
- Role of Complement Component 3 in Polycystic Kidney Disease Pathogenesis
- American Society of Nephrology
- New
- $100,000 7/1/09 - 6/30/10
- Paul Sanders, M.D.
- Mechanisms of Salt-Sensitive Hypertension and Hypertensive Nephrosclerosis
- NIH
- Non-Competing Continuation
- $301,963 7/1/09 - 6/30/10
June 2009
- Anupam Agarwal, M.D.
- Cytokine Modulation of Heme Oxygenase-1 in Chronic Kidney Transplant Rejection
- NIH
- Non-Competing Continuation
- $283,330 6/1/09 - 5/31/10
March 2009
- Ji-Bin Peng, M.D.
- Interplay of Renal Ca and Na Transport Pathways
- NIH
- Non-Competing Continuation
- $262,175 03/01/09 - 02/28/10
January 2009
- Zipporah Krishnasami, M.D.
- Evaluation of the Performance of GFR Estimating Equations in HIV Positive Patients.
- Tufts Medical Center
- New
- $80,079 01/14/09 - 01/13/10
- Denyse Thornley-Brown, M.D.
- A Phase I, Multicentre, Open-Label, Dose-Escalating Study of Single Doses of GC1008 in Patients with Treatment Resistant Idiopathic Focal Segmental Glomerulosclerosis (FSGS)
- Genzyme Corporation
- New
- $12,690 01/01/09 -12/31/09
- David Warnock, M.D.
- A 52-Week, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Phase Iib Trial to Determine the Effects of Bardoxolone Methyl (RTA 402) on eGFR in Subjects with Type 2 Diabetes and Chronic Kidney Disease with an Estimated GFR of 20-45mL/min/1.73m2
- Reata
- New
- $48,025 1/1/09 - 12/31/09